Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BLND NYSE:PSN NASDAQ:TEM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLNDBlend Labs$3.37-4.3%$3.49$2.37▼$5.53$875.05M1.242.87 million shs1.63 million shsPSNParsons$76.36-0.3%$69.87$54.56▼$114.68$8.16B0.551.22 million shs853,691 shsTEMTempus AI$60.98+0.5%$63.06$31.36▼$91.45$10.56BN/A7.70 million shs8.33 million shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLNDBlend Labs0.00%-3.02%+5.81%+11.22%+8.01%PSNParsons0.00%+2.02%+14.01%+20.90%-1.45%TEMTempus AI0.00%+7.21%-10.73%+48.80%+47.29%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLNDBlend Labs3.8022 of 5 stars4.43.00.00.02.33.30.6PSNParsons3.2625 of 5 stars3.41.00.00.02.91.72.5TEMTempus AI1.4541 of 5 stars2.32.00.00.01.92.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLNDBlend Labs 2.89Moderate Buy$4.9045.40% UpsidePSNParsons 2.75Moderate Buy$85.2011.58% UpsideTEMTempus AI 2.50Moderate Buy$65.096.74% UpsideCurrent Analyst Ratings BreakdownLatest TEM, PSN, BLND, and VTY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/16/2025PSNParsonsKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$73.00 ➝ $82.007/8/2025PSNParsonsRaymond James FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeMarket Perform ➝ Strong-Buy$90.007/2/2025PSNParsonsJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$70.00 ➝ $80.006/30/2025TEMTempus AIGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$65.00 ➝ $75.006/25/2025TEMTempus AIBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$68.00 ➝ $70.006/24/2025PSNParsonsStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$81.006/4/2025PSNParsonsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$90.00 ➝ $80.006/3/2025PSNParsonsBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$100.00 ➝ $95.005/28/2025BLNDBlend LabsJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$7.005/20/2025TEMTempus AIBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$48.00 ➝ $68.005/19/2025BLNDBlend LabsKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Perform ➝ Market Perform$3.50 ➝ $4.00(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLNDBlend Labs$162.02M5.40N/AN/A($0.22) per share-15.32PSNParsons$6.75B1.21$3.88 per share19.68$23.87 per share3.20TEMTempus AI$693.40M15.22N/AN/A$0.35 per share174.23Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLNDBlend Labs-$43.35M-$0.20N/AN/AN/A-22.72%N/A-13.37%8/7/2025 (Confirmed)PSNParsons$235.05M$2.3732.2218.624.563.86%13.01%5.91%8/6/2025 (Estimated)TEMTempus AI-$705.81M-$7.80N/AN/AN/A-88.27%-533.21%-66.19%8/5/2025 (Estimated)Latest TEM, PSN, BLND, and VTY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025BLNDBlend Labs$0.02N/AN/AN/A$31.93 millionN/A8/6/2025Q2 2025PSNParsons$0.76N/AN/AN/A$1.60 billionN/A8/5/2025Q2 2025TEMTempus AI-$0.23N/AN/AN/A$296.84 millionN/A5/6/2025Q1 2025TEMTempus AI-$0.27-$0.24+$0.03-$0.40$248.13 million$255.74 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLNDBlend LabsN/AN/AN/AN/AN/APSNParsonsN/AN/AN/AN/AN/ATEMTempus AIN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLNDBlend LabsN/A2.412.41PSNParsons0.311.291.29TEMTempus AI2.451.711.56Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLNDBlend Labs52.56%PSNParsons98.02%TEMTempus AI24.22%Insider OwnershipCompanyInsider OwnershipBLNDBlend Labs35.52%PSNParsons1.14%TEMTempus AI27.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLNDBlend Labs1,690259.66 million167.43 millionNot OptionablePSNParsons19,600106.88 million105.66 millionNot OptionableTEMTempus AI2,400173.12 million125.34 millionN/ATEM, PSN, BLND, and VTY HeadlinesRecent News About These CompaniesINVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Tempus AI, Inc. ...1 hour ago | gurufocus.comBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, Reckitt, and Tempus and Encourages Investors to Contact the FirmJuly 20 at 11:07 AM | globenewswire.comDiversify Advisory Services LLC Takes Position in Tempus AI, Inc. (NASDAQ:TEM)July 20 at 5:52 AM | marketbeat.comTempus AI, Inc. (NASDAQ:TEM) Stock Holdings Raised by Massachusetts Financial Services Co. MAJuly 19 at 5:49 AM | marketbeat.comTempus AI, Inc. (NASDAQ:TEM) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJuly 19 at 2:31 AM | marketbeat.comTEMPUS AI SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc. - TEMJuly 18 at 10:34 PM | prnewswire.comLooking At Tempus AI's Recent Unusual Options ActivityJuly 18 at 4:53 PM | benzinga.comDeadline Alert: Tempus AI, Inc. (TEM) Investors Who Lost Money Urged To Contact Glancy Prongay ...July 18 at 12:08 PM | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming Deadlines - TEMJuly 18 at 12:00 PM | globenewswire.comCity’s digital health sector sees funding uptick as life sciences, AI firms attract investorsJuly 18 at 11:48 AM | crainsnewyork.comCTempus AI (TEM) Gains FDA Clearance for New Cardiovascular Risk Detection SoftwareJuly 18 at 11:48 AM | finance.yahoo.comBridgewater Advisors Inc. Invests $259,000 in Tempus AI, Inc. (NASDAQ:TEM)July 18 at 6:15 AM | marketbeat.comTempus AI (NASDAQ:TEM) Trading 1.8% Higher - Should You Buy?July 17, 2025 | marketbeat.comTEM Shares Surge on New AI Breakthrough: Should Investors Jump In?July 17, 2025 | zacks.comTempus gets FDA OK for software to detect cardiac issueJuly 17, 2025 | chicagobusiness.comCTempus AI, Inc. (TEM) Investors Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitJuly 17, 2025 | prnewswire.comTempus AI, Inc. (TEM) and Personalis Join Forces to Take on Colorectal CancerJuly 17, 2025 | insidermonkey.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming Deadlines - TEMJuly 17, 2025 | prnewswire.comFDA grants 510(k) clearance for Tempus AI’s ejection fraction softwareJuly 17, 2025 | finance.yahoo.comBrown Advisory Inc. Invests $209,000 in Tempus AI, Inc. (NASDAQ:TEM)July 17, 2025 | marketbeat.comFrom Clinics to Cancer Labs, AI Is Unlocking a New $100B+ Era in MedicineJuly 16, 2025 | tmcnet.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Notable Stocks Just Split: Which One Could Be the Big Winner?By Leo Miller | June 26, 2025View 3 Notable Stocks Just Split: Which One Could Be the Big Winner?Rocket Lab: Europe Comes Calling as Momentum BuildsBy Ryan Hasson | June 27, 2025View Rocket Lab: Europe Comes Calling as Momentum BuildsAeva & Mobileye: LiDAR Stocks Powering the Autonomous RevolutionBy Dan Schmidt | July 2, 2025View Aeva & Mobileye: LiDAR Stocks Powering the Autonomous RevolutionSuper Micro Stock May Benefit as Cooling Demand Takes OffBy Gabriel Osorio-Mazilli | July 16, 2025View Super Micro Stock May Benefit as Cooling Demand Takes OffReddit Stock Ignites: Surge in Call Options Signals Big BetBy Gabriel Osorio-Mazilli | June 24, 2025View Reddit Stock Ignites: Surge in Call Options Signals Big BetTEM, PSN, BLND, and VTY Company DescriptionsBlend Labs NYSE:BLND$3.37 -0.15 (-4.26%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$3.36 -0.01 (-0.30%) As of 05:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Blend Labs, Inc. engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty. It also offers verification components to automate confirmation tasks that are needed to underwrite a loan or approve the opening of a new deposit account; decisioning components to reduce the need for human intervention by automatically applying business rules throughout an application workflow configured by a financial services firm; workflow intelligence components to manage data collection and automate tasks throughout the loan origination process; and marketplace components to enable consumers to shop for products and services presented at the precise moment of need during an application for a loan. In addition, the company, through its subsidiary, offers title search procedures for title insurance policies, escrow, and other closing and settlement services, as well as other trustee services; and provides professional and consulting services. It serves banks, credit unions, fintechs, and non-bank mortgage lenders. The company was incorporated in 2012 and is headquartered in San Francisco, California.Parsons NYSE:PSN$76.36 -0.23 (-0.30%) Closing price 07/18/2025 03:59 PM EasternExtended Trading$76.22 -0.14 (-0.18%) As of 05:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Parsons Corporation provides integrated solutions and services in the defense, intelligence, and critical infrastructure markets in North America, the Middle East, and internationally. The company operates through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment provides critical technologies, such as cybersecurity; missile defense; intelligence; space launch and ground systems; space and weapon system resiliency; geospatial intelligence; signals intelligence; environmental remediation; border security, critical infrastructure protection; counter unmanned air systems; biometrics and bio surveillance solutions to U.S. Department of Defense, including military services; Missile Defense Agency, the Department of Energy; the Department of State; the Department of Homeland Security, and the Federal Aviation Administration. The Critical Infrastructure segment provides management, design, and engineering services, as well as offers leveraging sensor solutions. This segment develops digital solutions for next generation aviation, rail and transit, bridges, roads, and highways; and provides water and wastewater treatment systems; AI/ML, and digital twin and cyber systems integration services; planning, engineering, and management services for infrastructure, including bridges and tunnels, roads and highways, water and wastewater, and dams and reservoirs. Parsons Corporation was founded in 1944 and is headquartered in Chantilly, Virginia.Tempus AI NASDAQ:TEM$60.98 +0.33 (+0.54%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$61.76 +0.79 (+1.29%) As of 06:18 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
